Currently Viewing:
ACCC Annual Meeting & Cancer Center Business Summit
Dr Allen Lichter: Technology Is Present in Oncology, but the Future Is Brighter
March 21, 2019
Envisioning the Future of Cancer Care
March 21, 2019
Joe Flower on Rethinking the Way We Address Cancer Care Delivery
March 21, 2019
Different Vantage Points, but Similar Goals of High-Value Care, Patient Satisfaction
March 22, 2019
Dr John Halamka Outlines Trends in Digital Health
March 22, 2019
Currently Reading
Feyi Olopade Ayodele Highlights How CancerIQ Helps With Genetic Testing
March 22, 2019
Erich Mounce Discusses How Community Oncology Can Address Inequalities in Cancer Care
March 23, 2019
Digital Health Lessons From Around the World
March 24, 2019
Dr Ali McBride Discusses the Role of Biosimilars in Oncology
March 25, 2019
Ben Jones Explains Reimbursement Challenges Facing Community Oncologists
April 04, 2019
Alexandra Quinn on the Importance of Sustaining the Role of Community Health Workers in Cancer Care
April 08, 2019
Erich Mounce Discusses How Technology Needs to Evolve to Help Oncologists Deliver Care
April 08, 2019
Ben Jones Weighs the Implications of Site-Neutral Payments
May 24, 2019
Erich Mounce Emphasizes the Importance of Palliative Care
June 01, 2019
Ben Jones Discusses the Impact of Step Therapy in Medicare Advantage
June 07, 2019
Erich Mounce: How Payment Models Are Changing the Way Oncologists Practice
June 14, 2019
Ben Jones: Oncologists Still Face Challenges When Trying to Extract Data From EHRs
June 19, 2019

Feyi Olopade Ayodele Highlights How CancerIQ Helps With Genetic Testing

CancerIQ is reducing barriers that make it difficult to utilize genetic testing to predict or pre-empt a patient’s cancer diagnosis, explained Feyi Olopade Ayodele, MBA, chief executive officer at CancerIQ.


CancerIQ is reducing barriers that make it difficult to utilize genetic testing to predict or pre-empt a patient’s cancer diagnosis, explained Feyi Olopade Ayodele, MBA, chief executive officer at CancerIQ.

Transcript

How is CancerIQ working to make genetic services more practical in predicting or preventing cancer?

So, CancerIQ is making it more practical to start predicting and pre-empting cancer by really trying to reduce some of the barriers that are really holding the industry back today. The first of those challenges is really knowledge. You know, to connect the dots on people’s family history, and their genetic testing information. Really stuff that the provider can’t do with the naked eye. So, it’s really through our software that we can automate the decisions that need to be made on the basis of that information, and make it relatively easy for the physician, who, quite frankly, didn’t study genetics when they were in medical school.

The second way that CancerIQ makes it practical for people to do this in routine care is being really mindful of the clinical workflow. Unfortunately, people are today using systems that are primarily oriented for billing and logging of information. And CancerIQ works really well with those systems in being a layer of intelligence on top of that. So, how we actually integrate into your everyday clinical workflow is really connecting to the systems that already exist but putting that layer of intelligence on top of it.

 
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up